Institute for Ophthalmic Research
Institut für Augenheilkunde
Centre for Neurosensory Systems
Research and Patient Care in Otolaryngology and Ophthalmology under a common roof
Due to the gratifying raised life expectancies in most industrialized countries neurosensory disorders increased significantly in the last decade. Currently, 80 million Europeans suffer from these diseases; every second German citizen will develop over his life a severe vision or hearing impairment. The reasons for the increase in this specific disease spectrum are complex. In addition to personal habits largely still unknown genetic factors contribute significantly. While in individual neurosensory disorders significant improvements in diagnosis and treatment have been achieved in recent years, in other, sometimes very frequent diseases acute research and development efforts are needed.
The Center for Neurosensory Systems as part of the Medical Faculty and the University Hospital in Tuebingen was established in early 2011. According to its statutes the main aim of the center is to gain insight into the various neurosensory areas by a thorough understanding of the common and different molecular, physiological and pathophysiological processes underlying these systems and to accelerate the results of basic research to the clinic.
More information on the website of the Center for Neurosensory Systems
Centre for Rare Eye Diseases
The eye is a complex part of the body and as a result there are many different conditions that have an impact on sight. Because of the rare incidence of some eye diseases, there is often little known about the conditions, their causes and treatment.
The Centre for Rare Eye Diseases in Tuebingen focus its research and patient care activities on the following conditions:
- Hereditary Retinal Degenerations
- Cone and Cone-Rod dystrophies
- Stargardt Disease
- Usher Syndrome
- Bilateral Optic Atrophies
- Rare forms of Glaucoma
STZ eyetrial Tübingen
STC eyetrial's task is to study the influence of medical treatment on the course of diseases or health impairments in humans, respectively, and by means of innovative methods to contribute to early diagnosis. STC eyetrial's studies and clinical trials therefore have a lasting effect regarding the improvement of medicines/pharmaceuticals as well as the development of novel medical therapeutic approaches, thus significantly contributing to new technical developments in industry.
More information: http://www.stz-biomed.de/eyetrial/stc-eyetrial.html
Helmholtz Zentrum Munich
Helmholtz Zentrum München is the German Research Center for Environmental Health. It investigates important common diseases which develop from the interaction of lifestyle, environmental factors and personal genetic background, focusing particularly on diabetes mellitus and chronic lung diseases. Helmholtz Zentrum München is a research institution of the Federal Republic of Germany and the Free State of Bavaria. It is a member of the Helmholtz Association of German Research Centers.
More information: http://www.helmholtz-muenchen.de/en/index.html